Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.82e-07	35	29	4	GO:0015020
GeneOntologyMolecularFunction	RNA polymerase II general transcription initiation factor activity	TAF1 TAF4 FOXA2	5.80e-05	52	29	3	GO:0016251
GeneOntologyMolecularFunction	UDP-glycosyltransferase activity	UGT2B4 UGT2B7 UGT2B28 UGT2B11	6.78e-05	153	29	4	GO:0008194
GeneOntologyMolecularFunction	general transcription initiation factor activity	TAF1 TAF4 FOXA2	1.30e-04	68	29	3	GO:0140223
GeneOntologyMolecularFunction	hexosyltransferase activity	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.34e-04	211	29	4	GO:0016758
GeneOntologyMolecularFunction	retinoic acid binding	UGT2B4 UGT2B7	7.52e-04	28	29	2	GO:0001972
GeneOntologyMolecularFunction	glycosyltransferase activity	UGT2B4 UGT2B7 UGT2B28 UGT2B11	7.57e-04	288	29	4	GO:0016757
GeneOntologyMolecularFunction	retinoid binding	UGT2B4 UGT2B7	2.20e-03	48	29	2	GO:0005501
GeneOntologyMolecularFunction	isoprenoid binding	UGT2B4 UGT2B7	2.30e-03	49	29	2	GO:0019840
GeneOntologyBiologicalProcess	biphenyl catabolic process	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.53e-10	8	30	4	GO:0070980
GeneOntologyBiologicalProcess	biphenyl metabolic process	UGT2B4 UGT2B7 UGT2B28 UGT2B11	7.59e-10	10	30	4	GO:0018879
GeneOntologyBiologicalProcess	xenobiotic glucuronidation	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.78e-09	12	30	4	GO:0052697
GeneOntologyBiologicalProcess	cellular glucuronidation	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.14e-08	21	30	4	GO:0052695
GeneOntologyBiologicalProcess	glucuronate metabolic process	UGT2B4 UGT2B7 UGT2B28 UGT2B11	5.32e-08	26	30	4	GO:0019585
GeneOntologyBiologicalProcess	uronic acid metabolic process	UGT2B4 UGT2B7 UGT2B28 UGT2B11	5.32e-08	26	30	4	GO:0006063
GeneOntologyBiologicalProcess	benzene-containing compound metabolic process	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.32e-07	37	30	4	GO:0042537
GeneOntologyBiologicalProcess	xenobiotic catabolic process	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.32e-07	37	30	4	GO:0042178
GeneOntologyBiologicalProcess	androgen metabolic process	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.59e-07	38	30	4	GO:0008209
GeneOntologyBiologicalProcess	estrogen metabolic process	UGT2B4 UGT2B7 UGT2B28 UGT2B11	9.38e-07	52	30	4	GO:0008210
GeneOntologyBiologicalProcess	cellular response to xenobiotic stimulus	UGT2B4 UGT2B7 UGT2B28 UGT2B11 RECQL5	1.58e-05	222	30	5	GO:0071466
GeneOntologyBiologicalProcess	regulation of hormone levels	UGT2B4 UGT2B7 UGT2B28 UGT2B11 FOXA2 CTSB BAIAP3	4.47e-05	684	30	7	GO:0010817
GeneOntologyBiologicalProcess	xenobiotic metabolic process	UGT2B4 UGT2B7 UGT2B28 UGT2B11	4.99e-05	141	30	4	GO:0006805
GeneOntologyBiologicalProcess	hormone metabolic process	UGT2B4 UGT2B7 UGT2B28 UGT2B11 CTSB	5.31e-05	286	30	5	GO:0042445
GeneOntologyBiologicalProcess	response to xenobiotic stimulus	UGT2B4 UGT2B7 SCN11A UGT2B28 UGT2B11 RECQL5	9.33e-05	525	30	6	GO:0009410
GeneOntologyBiologicalProcess	steroid metabolic process	UGT2B4 UGT2B7 UGT2B28 UGT2B11 FOXA2	1.92e-04	376	30	5	GO:0008202
GeneOntologyCellularComponent	nuclear outer membrane	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.04e-07	40	30	4	GO:0005640
GeneOntologyCellularComponent	organelle outer membrane	UGT2B4 UGT2B7 UGT2B28 UGT2B11	6.47e-04	279	30	4	GO:0031968
GeneOntologyCellularComponent	outer membrane	UGT2B4 UGT2B7 UGT2B28 UGT2B11	6.65e-04	281	30	4	GO:0019867
GeneOntologyCellularComponent	MLL1 complex	TAF1 TAF4	9.61e-04	32	30	2	GO:0071339
GeneOntologyCellularComponent	MLL1/2 complex	TAF1 TAF4	1.02e-03	33	30	2	GO:0044665
GeneOntologyCellularComponent	nuclear membrane	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.49e-03	349	30	4	GO:0031965
GeneOntologyCellularComponent	axonal growth cone	SCN11A PALLD	1.90e-03	45	30	2	GO:0044295
GeneOntologyCellularComponent	transcription factor TFIID complex	TAF1 TAF4	2.07e-03	47	30	2	GO:0005669
Domain	UDPGT	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.64e-08	21	31	4	PS00375
Domain	UDPGT	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.64e-08	21	31	4	PF00201
Domain	UDP_glucos_trans	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.64e-08	21	31	4	IPR002213
Domain	-	FOXA2 RECQL5 FOXD4 H1-2	4.44e-04	218	31	4	1.10.10.10
Domain	WHTH_DNA-bd_dom	FOXA2 RECQL5 FOXD4 H1-2	6.57e-04	242	31	4	IPR011991
Domain	TF_fork_head_CS_2	FOXA2 FOXD4	2.64e-03	46	31	2	IPR030456
Domain	TF_fork_head_CS_1	FOXA2 FOXD4	2.75e-03	47	31	2	IPR018122
Domain	FORK_HEAD_3	FOXA2 FOXD4	2.99e-03	49	31	2	PS50039
Domain	FH	FOXA2 FOXD4	2.99e-03	49	31	2	SM00339
Domain	FORK_HEAD_1	FOXA2 FOXD4	2.99e-03	49	31	2	PS00657
Domain	FORK_HEAD_2	FOXA2 FOXD4	2.99e-03	49	31	2	PS00658
Domain	Forkhead	FOXA2 FOXD4	2.99e-03	49	31	2	PF00250
Domain	Fork_head_dom	FOXA2 FOXD4	2.99e-03	49	31	2	IPR001766
Domain	ZF_DAG_PE_1	TNS2 CDC42BPA	5.04e-03	64	31	2	PS00479
Domain	ZF_DAG_PE_2	TNS2 CDC42BPA	5.04e-03	64	31	2	PS50081
Domain	C1	TNS2 CDC42BPA	5.20e-03	65	31	2	SM00109
Domain	PE/DAG-bd	TNS2 CDC42BPA	5.35e-03	66	31	2	IPR002219
Domain	Ion_trans_dom	SCN11A KCNB2	1.53e-02	114	31	2	IPR005821
Domain	Ion_trans	SCN11A KCNB2	1.53e-02	114	31	2	PF00520
Pathway	REACTOME_PREDNISONE_ADME	UGT2B4 UGT2B7 UGT2B28 UGT2B11	4.67e-08	23	23	4	MM16639
Pathway	REACTOME_GLUCURONIDATION	UGT2B4 UGT2B7 UGT2B28 UGT2B11	5.60e-08	24	23	4	MM14599
Pathway	WP_GLUCURONIDATION	UGT2B4 UGT2B7 UGT2B28 UGT2B11	6.66e-08	25	23	4	MM15820
Pathway	REACTOME_GLUCURONIDATION	UGT2B4 UGT2B7 UGT2B28 UGT2B11	6.66e-08	25	23	4	M17787
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT2B4 UGT2B7 UGT2B28 UGT2B11	6.66e-08	25	23	4	M605
Pathway	WP_GLUCURONIDATION	UGT2B4 UGT2B7 UGT2B28 UGT2B11	7.86e-08	26	23	4	M39404
Pathway	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.07e-07	28	23	4	M19580
Pathway	REACTOME_PARACETAMOL_ADME	UGT2B4 UGT2B7 UGT2B28 UGT2B11	4.26e-07	39	23	4	MM15695
Pathway	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	UGT2B4 UGT2B7 UGT2B28 UGT2B11	5.24e-07	41	23	4	M7399
Pathway	REACTOME_ASPIRIN_ADME	UGT2B4 UGT2B7 UGT2B28 UGT2B11	7.00e-07	44	23	4	M45014
Pathway	REACTOME_ASPIRIN_ADME	UGT2B4 UGT2B7 UGT2B28 UGT2B11	7.67e-07	45	23	4	MM15694
Pathway	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.28e-06	51	23	4	M17726
Pathway	KEGG_STARCH_AND_SUCROSE_METABOLISM	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.38e-06	52	23	4	M14171
Pathway	KEGG_STEROID_HORMONE_BIOSYNTHESIS	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.74e-06	55	23	4	M14933
Pathway	KEGG_RETINOL_METABOLISM	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.21e-06	64	23	4	M9488
Pathway	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	UGT2B4 UGT2B7 UGT2B28 UGT2B11	4.60e-06	70	23	4	M16794
Pathway	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	UGT2B4 UGT2B7 UGT2B28 UGT2B11	5.15e-06	72	23	4	M9257
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.49e-05	107	23	4	MM14595
Pathway	REACTOME_DRUG_ADME	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.67e-05	109	23	4	M45012
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.67e-05	109	23	4	M18788
Pathway	REACTOME_DRUG_ADME	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.78e-05	119	23	4	MM15692
Pathway	WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.01e-04	183	23	4	M39588
Pathway	WP_CODEINE_AND_MORPHINE_METABOLISM	UGT2B4 UGT2B7	2.29e-04	14	23	2	M39328
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.98e-04	219	23	4	MM14838
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	UGT2B4 UGT2B7 UGT2B28 UGT2B11	4.05e-04	220	23	4	M10320
Pathway	KEGG_BASAL_TRANSCRIPTION_FACTORS	TAF1 TAF4	1.47e-03	35	23	2	M4864
Pathway	REACTOME_HIV_TRANSCRIPTION_INITIATION	TAF1 TAF4	2.63e-03	47	23	2	M29568
Pathway	REACTOME_RNA_POLYMERASE_II_PROMOTER_ESCAPE	TAF1 TAF4	2.74e-03	48	23	2	MM15424
Pathway	REACTOME_RAC1_GTPASE_CYCLE	DOCK10 NHS CDC42BPA	2.77e-03	175	23	3	MM15599
Pathway	REACTOME_RAC1_GTPASE_CYCLE	DOCK10 NHS CDC42BPA	3.20e-03	184	23	3	M41809
Pathway	REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME	TAF1 TAF4	5.75e-03	70	23	2	M27008
Pathway	REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS	TAF1 TAF4	7.63e-03	81	23	2	M865
Pathway	REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS	TAF1 TAF4	8.00e-03	83	23	2	MM15314
Pubmed	Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.80e-11	7	31	4	26074487
Pubmed	Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.60e-11	8	31	4	32093886
Pubmed	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.58e-07	66	31	4	19898482
Pubmed	Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33.	UGT2B4 UGT2B7	7.69e-07	2	31	2	17263731
Pubmed	Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate.	UGT2B4 UGT2B7	7.69e-07	2	31	2	10222050
Pubmed	Quantitative analysis of UGT2B28 mRNA expression by real-time RT-PCR and application to human tissue distribution study.	UGT2B28 UGT2B11	7.69e-07	2	31	2	21679149
Pubmed	Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population.	UGT2B4 UGT2B7	7.69e-07	2	31	2	15319348
Pubmed	Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13.	UGT2B4 UGT2B7	2.31e-06	3	31	2	7835904
Pubmed	cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily.	UGT2B4 UGT2B11	2.31e-06	3	31	2	8333863
Pubmed	Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects.	UGT2B4 UGT2B7	2.31e-06	3	31	2	22092298
Pubmed	Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions .	UGT2B4 UGT2B7	2.31e-06	3	31	2	29138287
Pubmed	Contribution of polymorphisms in UDP-glucuronosyltransferase and CYP2D6 to the individual variation in disposition of carvedilol.	UGT2B4 UGT2B7	4.61e-06	4	31	2	16849011
Pubmed	UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients.	UGT2B4 UGT2B7	7.68e-06	5	31	2	15318931
Pubmed	Dominant and redundant functions of TFIID involved in the regulation of hepatic genes.	TAF1 TAF4 FOXA2	7.72e-06	43	31	3	18722179
Pubmed	Positive and negative TAF(II) functions that suggest a dynamic TFIID structure and elicit synergy with traps in activator-induced transcription.	TAF1 TAF4	1.15e-05	6	31	2	11564872
Pubmed	Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response.	TAF1 TAF4	1.15e-05	6	31	2	24289924
Pubmed	Human TAFII 105 is a cell type-specific TFIID subunit related to hTAFII130.	TAF1 TAF4	1.15e-05	6	31	2	8858156
Pubmed	Essential role of the TFIID subunit TAF4 in murine embryogenesis and embryonic stem cell differentiation.	TAF1 TAF4 FOXA2	1.22e-05	50	31	3	27026076
Pubmed	Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.	UGT2B7 UGT2B28	1.61e-05	7	31	2	20056642
Pubmed	Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID.	TAF1 TAF4	1.61e-05	7	31	2	7729427
Pubmed	Core promoter binding by histone-like TAF complexes.	TAF1 TAF4	2.15e-05	8	31	2	15601843
Pubmed	Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine.	UGT2B4 UGT2B7	2.15e-05	8	31	2	10748067
Pubmed	Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms.	UGT2B4 UGT2B7	2.15e-05	8	31	2	18052087
Pubmed	The mouse fkh-2 gene. Implications for notochord, foregut, and midbrain regionalization.	FOXA2 FOXD4	2.15e-05	8	31	2	8530406
Pubmed	The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.	UGT2B4 UGT2B7	2.15e-05	8	31	2	18719240
Pubmed	Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States.	UGT2B4 UGT2B7	2.15e-05	8	31	2	20142249
Pubmed	Association study between single-nucleotide polymorphisms in 199 drug-related genes and commonly measured quantitative traits of 752 healthy Japanese subjects.	UGT2B4 UGT2B7 UGT2B11 NDUFV2	2.57e-05	193	31	4	19343046
Pubmed	The intracellular localisation of TAF7L, a paralogue of transcription factor TFIID subunit TAF7, is developmentally regulated during male germ-cell differentiation.	TAF1 TAF4	2.76e-05	9	31	2	12665565
Pubmed	CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues.	TAF1 TAF4	4.21e-05	11	31	2	9153318
Pubmed	Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.	UGT2B4 UGT2B7	5.05e-05	12	31	2	20308471
Pubmed	Detoxification enzyme polymorphisms are not involved in duodenal adenomatosis in familial adenomatous polyposis.	UGT2B4 UGT2B7	5.05e-05	12	31	2	18161889
Pubmed	Requirement of tissue-selective TBP-associated factor TAFII105 in ovarian development.	TAF1 TAF4	5.96e-05	13	31	2	11557891
Pubmed	Transcription factor TFIID recruits factor CPSF for formation of 3' end of mRNA.	TAF1 TAF4	5.96e-05	13	31	2	9311784
Pubmed	Structure of promoter-bound TFIID and model of human pre-initiation complex assembly.	TAF1 TAF4	6.95e-05	14	31	2	27007846
Pubmed	Human TFIID binds to core promoter DNA in a reorganized structural state.	TAF1 TAF4	6.95e-05	14	31	2	23332750
Pubmed	The TBN protein, which is essential for early embryonic mouse development, is an inducible TAFII implicated in adipogenesis.	TAF1 TAF4	8.02e-05	15	31	2	14580349
Pubmed	Six members of the mouse forkhead gene family are developmentally regulated.	FOXA2 FOXD4	8.02e-05	15	31	2	7689224
Pubmed	Wild-type and transactivation-defective mutants of human immunodeficiency virus type 1 Tat protein bind human TATA-binding protein in vitro.	TAF1 TAF4	9.16e-05	16	31	2	8680883
Pubmed	Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarly.	TAF1 TAF4	9.16e-05	16	31	2	8764009
Pubmed	Direct interaction of human TFIID with the HIV-1 transactivator tat.	TAF1 TAF4	9.16e-05	16	31	2	8121496
Pubmed	A novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitro.	TAF1 TAF4	9.16e-05	16	31	2	7836461
Pubmed	Developmental competence of the gut endoderm: genetic potentiation by GATA and HNF3/fork head proteins.	FOXA2 FOXD4	9.16e-05	16	31	2	10208738
Pubmed	Novel mechanism and factor for regulation by HIV-1 Tat.	TAF1 TAF4	9.16e-05	16	31	2	7835343
Pubmed	Histone-like TAFs within the PCAF histone acetylase complex.	TAF1 TAF4	1.04e-04	17	31	2	9674425
Pubmed	Architecture of TAF11/TAF13/TBP complex suggests novel regulation properties of general transcription factor TFIID.	TAF1 TAF4	1.17e-04	18	31	2	29111974
Pubmed	Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.	UGT2B4 UGT2B7	1.17e-04	18	31	2	20056724
Pubmed	Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression.	TAF1 TAF4	1.17e-04	18	31	2	15053879
Pubmed	Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function.	TAF1 TAF4	1.17e-04	18	31	2	7933101
Pubmed	Functional equivalency between Otx2 and Otx1 in development of the rostral head.	FOXA2 FOXD4	1.30e-04	19	31	2	9895322
Pubmed	Interaction of human immunodeficiency virus type 1 Tat with a unique site of TFIID inhibits negative cofactor Dr1 and stabilizes the TFIID-TFIIA complex.	TAF1 TAF4	1.30e-04	19	31	2	8764062
Pubmed	Lost in transcription: molecular mechanisms that control HIV latency.	TAF1 TAF4	1.30e-04	19	31	2	23518577
Pubmed	Function of TAF(II)-containing complex without TBP in transcription by RNA polymerase II.	TAF1 TAF4	1.45e-04	20	31	2	9603525
Pubmed	Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4.	TAF1 TAF4	1.45e-04	20	31	2	17884155
Pubmed	STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferation.	TAF1 TAF4	1.45e-04	20	31	2	17967894
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	MSL1 TAF1 TAF4 RECQL5 NDUFV2 H1-2	1.72e-04	954	31	6	36373674
Pubmed	Crucial roles of Foxa2 in mouse anterior-posterior axis polarization via regulation of anterior visceral endoderm-specific genes.	FOXA2 FOXD4	1.76e-04	22	31	2	17389379
Pubmed	Selective recognition of viral promoters by host cell transcription complexes: challenges and opportunities to control latency.	TAF1 TAF4	2.10e-04	24	31	2	23827503
Pubmed	Otx2 is required to respond to signals from anterior neural ridge for forebrain specification.	FOXA2 FOXD4	2.10e-04	24	31	2	11820816
Pubmed	Identification of transcripts with enriched expression in the developing and adult pancreas.	UGT2B4 UGT2B7 UGT2B28 UGT2B11 FOXA2	2.11e-04	624	31	5	18554416
Pubmed	The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function.	TAF1 TAF4	2.28e-04	25	31	2	19240132
Pubmed	Ssdp1 regulates head morphogenesis of mouse embryos by activating the Lim1-Ldb1 complex.	FOXA2 FOXD4	2.47e-04	26	31	2	15857913
Pubmed	Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.	TAF1 TAF4	3.52e-04	31	31	2	15960975
Pubmed	Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo.	TAF1 TAF4	3.99e-04	33	31	2	11564863
Pubmed	Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease.	FOXA2 CTSB	4.24e-04	34	31	2	25915474
Pubmed	Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer.	UGT2B4 UGT2B11	5.30e-04	38	31	2	20214802
Pubmed	Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexes.	TAF1 TAF4	5.58e-04	39	31	2	9054383
Pubmed	The general transcription factors of RNA polymerase II.	TAF1 TAF4	5.58e-04	39	31	2	8946909
Pubmed	Three transitions in the RNA polymerase II transcription complex during initiation.	TAF1 TAF4	5.58e-04	39	31	2	9405375
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	ERFE PALLD H1-2	5.87e-04	184	31	3	32908313
Pubmed	Abortive initiation is increased only for the weakest members of a set of down mutants of the adenovirus 2 major late promoter.	TAF1 TAF4	5.87e-04	40	31	2	1939271
Pubmed	ATP activates transcription initiation from promoters by RNA polymerase II in a reversible step prior to RNA synthesis.	TAF1 TAF4	5.87e-04	40	31	2	2449431
Pubmed	Impact of WIN site inhibitor on the WDR5 interactome.	MSL1 TAF1	6.79e-04	43	31	2	33472061
Pubmed	Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat.	TAF1 TAF4	7.77e-04	46	31	2	8849451
Pubmed	TAF4, a subunit of transcription factor II D, directs promoter occupancy of nuclear receptor HNF4A during post-natal hepatocyte differentiation.	TAF1 TAF4	7.77e-04	46	31	2	25209997
Cytoband	Ensembl 112 genes in cytogenetic band chr4q13	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.85e-06	157	31	4	chr4q13
Cytoband	4q13	UGT2B4 UGT2B7	4.61e-05	15	31	2	4q13
Cytoband	4q13.2	UGT2B28 UGT2B11	2.03e-04	31	31	2	4q13.2
Cytoband	16p13.3	BRICD5 BAIAP3	1.18e-02	244	31	2	16p13.3
GeneFamily	UDP glucuronosyltransferases	UGT2B4 UGT2B7 UGT2B28 UGT2B11	5.78e-08	32	22	4	363
GeneFamily	Forkhead boxes	FOXA2 FOXD4	1.24e-03	43	22	2	508
Coexpression	WENG_POR_TARGETS_LIVER_UP	UGT2B4 UGT2B7 UGT2B28 UGT2B11	4.50e-07	53	31	4	MM1203
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	UGT2B4 DOCK10 UGT2B7 UGT2B28 UGT2B11 PALLD	6.28e-07	267	31	6	MM984
Coexpression	VANLOO_SP3_TARGETS_DN	UGT2B4 UGT2B7 UGT2B28 UGT2B11	6.52e-06	103	31	4	MM919
Coexpression	SERVITJA_ISLET_HNF1A_TARGETS_DN	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.23e-05	121	31	4	MM935
Coexpression	SERVITJA_LIVER_HNF1A_TARGETS_DN	UGT2B4 UGT2B7 UGT2B28 UGT2B11	7.22e-05	190	31	4	MM1311
Coexpression	OHGUCHI_LIVER_HNF4A_TARGETS_DN	UGT2B4 UGT2B7 UGT2B28 UGT2B11	8.98e-05	201	31	4	MM1294
Coexpression	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	UGT2B7 PALLD	1.05e-04	13	31	2	M2096
Coexpression	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	UGT2B7 UGT2B11	1.82e-04	17	31	2	M9914
Coexpression	BOCHKIS_FOXA2_TARGETS	UGT2B4 UGT2B7 UGT2B28 UGT2B11 FOXA2	2.04e-04	467	31	5	MM1233
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery\|Children_(3_yrs) / Lineage, Cell type, age group and donor	JCAD GPR17 SEMA3G CDC42BPA	8.87e-06	190	31	4	f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	JCAD GPR17 SEMA3G CDC42BPA	9.05e-06	191	31	4	50601ef0a5a8f2c2120922989e08e85bf2d9b4ab
Computational	Genes in the cancer module 227.	UGT2B4 UGT2B7	4.13e-04	15	22	2	MODULE_227
Computational	Steroid hormone and heme metabolism.	UGT2B4 UGT2B7	4.72e-04	16	22	2	MODULE_505
Drug	C1 11-32	UGT2B4 UGT2B7 UGT2B28 UGT2B11	8.49e-09	18	31	4	CID000443077
Drug	C11131	UGT2B4 UGT2B7 UGT2B28 UGT2B11	8.49e-09	18	31	4	CID000443076
Drug	T4-G	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.07e-08	19	31	4	CID000152424
Drug	estriol-16-glucuronide	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.66e-08	21	31	4	CID000122281
Drug	3-OHBaP	UGT2B4 UGT2B7 UGT2B28 UGT2B11 BAIAP3	2.22e-08	63	31	5	CID000025890
Drug	estradiol-3-glucuronide	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.44e-08	23	31	4	CID000066651
Drug	L-idaro-1,4-lactone	UGT2B4 UGT2B7 UGT2B28 UGT2B11	5.63e-08	28	31	4	CID000078997
Drug	7-hydroxycoumarin glucuronide	UGT2B4 UGT2B7 UGT2B28 UGT2B11	6.52e-08	29	31	4	CID000125641
Drug	AC1Q6OQG	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.12e-07	33	31	4	CID000009686
Drug	BP-3,6-quinol	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.12e-07	33	31	4	CID000119292
Drug	AC1NOWCJ	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.43e-07	35	31	4	CID005120112
Drug	3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.43e-07	35	31	4	CID010436171
Drug	estrone-3-glucuronide	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.43e-07	35	31	4	CID000115255
Drug	l-borneol	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.80e-07	37	31	4	CID000010049
Drug	harmol	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.48e-07	40	31	4	CID000068094
Drug	testosterone glucuronide	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.75e-07	41	31	4	CID000108192
Drug	2-AF	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.75e-07	41	31	4	CID000005800
Drug	androsterone glucuronide	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.34e-07	43	31	4	CID000114833
Drug	7,8-benzoquinoline	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.34e-07	43	31	4	CID000009191
Drug	MS-222	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.67e-07	44	31	4	CID000011400
Drug	salicylamide	UGT2B4 UGT2B7 UGT2B28 UGT2B11	5.25e-07	48	31	4	CID000005147
Drug	AC1NQGK1	UGT2B4 UGT2B7 UGT2B28 UGT2B11	7.27e-07	52	31	4	CID005195977
Drug	oxazepam	UGT2B4 UGT2B7 UGT2B28 UGT2B11	7.86e-07	53	31	4	CID000004616
Drug	7-methoxycoumarin	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.06e-06	57	31	4	CID000010748
Drug	phenolphthalein	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.13e-06	58	31	4	CID000004764
Drug	urochloralic acid	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.21e-06	59	31	4	CID003036914
Drug	4-hydroxybiphenyl	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.21e-06	59	31	4	CID000007103
Drug	4-hydroxyestrone	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.21e-06	59	31	4	CID000018418
Drug	acetaminophen glucuronide	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.21e-06	59	31	4	CID000083944
Drug	SN-38G	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.21e-06	59	31	4	CID000443154
Drug	UDP-alpha-d-xylopyranose	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.30e-06	60	31	4	CID000001165
Drug	2-hydroxyestriol	UGT2B7 UGT2B11	1.79e-06	2	31	2	ctd:C008012
Drug	Meldola	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.15e-06	68	31	4	CID000081507
Drug	methoxyresorufin	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.28e-06	69	31	4	CID000119220
Drug	AC1LCF1F	UGT2B4 UGT2B7 UGT2B28 UGT2B11 BAIAP3	2.43e-06	161	31	5	CID000627275
Drug	2,2,2-trichloroethanol	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.87e-06	73	31	4	CID000008259
Drug	eugenol	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.87e-06	73	31	4	CID000003314
Drug	7-hydroxycoumarin	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.19e-06	75	31	4	CID005281426
Drug	16-epiestriol	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.55e-06	77	31	4	CID000003269
Drug	AC1N8H7N	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.74e-06	78	31	4	CID004318740
Drug	benzyloxyresorufin	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.74e-06	78	31	4	CID000114982
Drug	acridine	UGT2B4 UGT2B7 UGT2B28 UGT2B11	4.35e-06	81	31	4	CID000009215
Drug	SN-38	UGT2B4 UGT2B7 UGT2B28 UGT2B11 H1-2	4.68e-06	184	31	5	CID000104842
Drug	5 alpha-androstane	UGT2B4 UGT2B7 UGT2B28 UGT2B11	5.03e-06	84	31	4	CID000094144
Drug	Hymecromone	UGT2B4 UGT2B7 UGT2B11	5.15e-06	25	31	3	ctd:D006923
Drug	DNCB	UGT2B4 UGT2B7 UGT2B28 UGT2B11 CTSB	5.33e-06	189	31	5	CID000000006
Drug	5 alpha-dihydroaldosterone	UGT2B4 UGT2B7	5.38e-06	3	31	2	CID003036614
Drug	7-ethoxycoumarin	UGT2B4 UGT2B7 UGT2B28 UGT2B11	5.52e-06	86	31	4	CID000035703
Drug	menthol	UGT2B4 UGT2B7 UGT2B28 UGT2B11	5.78e-06	87	31	4	CID000001254
Drug	pentoxyresorufin	UGT2B4 UGT2B7 UGT2B28 UGT2B11	5.78e-06	87	31	4	CID000107683
Drug	Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A	SCN11A ZCWPW1 GPR17 SEMA3G CDC42BPA	6.52e-06	197	31	5	4299_UP
Drug	4-aminobiphenyl	UGT2B4 UGT2B7 UGT2B28 UGT2B11	7.22e-06	92	31	4	CID000007102
Drug	p-nitroanisole	UGT2B4 UGT2B7 UGT2B28 UGT2B11	7.22e-06	92	31	4	CID000007485
Drug	2-naphthol	UGT2B4 UGT2B7 UGT2B28 UGT2B11	7.54e-06	93	31	4	CID000008663
Drug	DCNB	UGT2B4 UGT2B7 UGT2B28 UGT2B11	8.21e-06	95	31	4	CID000007443
Drug	ethoxyresorufin	UGT2B4 UGT2B7 UGT2B28 UGT2B11	8.21e-06	95	31	4	CID000003294
Drug	DB04103	UGT2B4 UGT2B7 UGT2B28 UGT2B11	8.92e-06	97	31	4	CID004469987
Drug	1-naphthol	UGT2B4 UGT2B7 UGT2B28 UGT2B11	9.29e-06	98	31	4	CID000007005
Drug	3-hydroxyandrostan-17-one	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.09e-05	102	31	4	CID000000225
Drug	chrysin	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.27e-05	106	31	4	CID005281607
Drug	fluconazole	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.32e-05	107	31	4	CID000003365
Drug	buthionine sulfoximine	UGT2B4 UGT2B7 UGT2B28 UGT2B11 BAIAP3	1.35e-05	229	31	5	CID000021157
Drug	2-naphthylamine	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.47e-05	110	31	4	CID000007057
Drug	hyodeoxycholic acid	UGT2B4 UGT2B7	1.79e-05	5	31	2	ctd:C010471
Drug	Amobarbital	UGT2B4 UGT2B7	1.79e-05	5	31	2	ctd:D000654
Drug	phenolphthalin	UGT2B4 UGT2B7	1.79e-05	5	31	2	CID000066494
Drug	lithocholic acid	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.81e-05	116	31	4	CID000009903
Drug	ethoxyquin	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.81e-05	116	31	4	CID000003293
Drug	AC1Q7AUJ	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.87e-05	117	31	4	CID000003303
Drug	fibrates	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.94e-05	118	31	4	CID000002797
Drug	alpha-naphthoflavone	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.94e-05	118	31	4	CID000011790
Drug	UDP-glucose	UGT2B4 UGT2B7 GPR17 UGT2B28 UGT2B11	1.95e-05	247	31	5	CID000001166
Drug	benzphetamine	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.00e-05	119	31	4	CID000002341
Drug	phenolate	UGT2B4 UGT2B7 UGT2B28 UGT2B11 BAIAP3	2.23e-05	254	31	5	CID000000996
Drug	2-acetylaminofluorene	UGT2B4 UGT2B7 TAF4 UGT2B28 UGT2B11	2.58e-05	262	31	5	CID000005897
Drug	hexobarbital	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.58e-05	127	31	4	CID000003608
Drug	Estriol	UGT2B4 UGT2B7 UGT2B11 FOXA2	2.67e-05	128	31	4	ctd:D004964
Drug	2-hydroxyestriol	UGT2B4 UGT2B7	2.68e-05	6	31	2	CID000014688
Drug	AC1L1FK5	UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.75e-05	129	31	4	CID000003272
Drug	4-methylumbelliferone	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.01e-05	132	31	4	CID003364573
Drug	oltipraz	UGT2B4 UGT2B7 UGT2B28 UGT2B11	3.48e-05	137	31	4	CID000047318
Drug	oxazepam glucuronide	UGT2B4 UGT2B7	3.75e-05	7	31	2	CID000160870
Drug	ranirestat	UGT2B4 UGT2B7	3.75e-05	7	31	2	ctd:C115070
Drug	aniline	UGT2B4 UGT2B7 UGT2B28 UGT2B11	4.00e-05	142	31	4	CID000006115
Drug	butylated hydroxytoluene	UGT2B4 UGT2B7 UGT2B28 UGT2B11	4.11e-05	143	31	4	CID000031404
Drug	2 E1	UGT2B4 UGT2B7 UGT2B28 UGT2B11	4.34e-05	145	31	4	CID006102788
Drug	disulfiram	UGT2B4 UGT2B7 UGT2B28 UGT2B11	6.07e-05	158	31	4	CID000003117
Drug	Racemic mixture	UGT2B4 UGT2B7 TAF1	6.70e-05	58	31	3	CID000365464
Drug	al-Badry	UGT2B4 UGT2B7 UGT2B28 UGT2B11	7.18e-05	165	31	4	CID000004545
Drug	estrone-d4	UGT2B4 UGT2B7 UGT2B28 UGT2B11	7.70e-05	168	31	4	CID000000698
Drug	aminopyrine	UGT2B4 UGT2B7 UGT2B28 UGT2B11	8.25e-05	171	31	4	CID000006009
Drug	glucosiduronate	UGT2B4 UGT2B7 UGT2B28 UGT2B11	8.25e-05	171	31	4	CID000000610
Drug	4-nitrophenol	UGT2B4 UGT2B7 UGT2B28 UGT2B11	9.43e-05	177	31	4	CID000000980
Drug	1,4-benzodiazepine	UGT2B4 UGT2B7	9.79e-05	11	31	2	CID000148431
Drug	zomepirac	UGT2B4 UGT2B7	9.79e-05	11	31	2	CID000005733
Drug	Tamoxifen citrate [54965-24-1]; Up 200; 7uM; MCF7; HT_HG-U133A	SCN11A SEMA3G BAIAP3 H1-2	1.03e-04	181	31	4	2212_UP
Drug	benzo(a)pyrene	UGT2B4 UGT2B7 UGT2B28 UGT2B11 BAIAP3	1.13e-04	358	31	5	CID000002336
Drug	4-hydroxyestrone	UGT2B7 UGT2B11	1.17e-04	12	31	2	ctd:C026418
Drug	uridine 5'-diphosphoglucuronic acid	UGT2B4 UGT2B7 UGT2B28 UGT2B11	1.21e-04	189	31	4	CID000000390
Drug	Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A	ZCWPW1 TAF1 CDC42BPA RECQL5	1.34e-04	194	31	4	3321_DN
Disease	plasma clozapine-to-N-desmethylclozapine ratio measurement	UGT2B4 UGT2B7 UGT2B11	8.78e-08	9	31	3	EFO_0600040
Disease	X-19141 measurement	UGT2B4 UGT2B7 UGT2B11	2.98e-07	13	31	3	EFO_0800799
Disease	phosphatidylcholine 36:4 measurement	UGT2B4 UGT2B28 UGT2B11	8.48e-07	18	31	3	EFO_0010382
Disease	X-24947 measurement	UGT2B4 UGT2B7 UGT2B11	1.60e-06	22	31	3	EFO_0800910
Disease	vitamin D deficiency	UGT2B4 UGT2B7 UGT2B11	7.96e-06	37	31	3	EFO_0003762
Disease	disease progression measurement	UGT2B4 UGT2B7 UGT2B11	3.63e-05	61	31	3	EFO_0008336
Disease	platelet component distribution width	DOCK10 JCAD SCN11A ZCWPW1 C22orf31 NDUFV2	1.17e-04	755	31	6	EFO_0007984
Disease	bacteriemia	UGT2B4 PALLD	1.44e-04	17	31	2	EFO_0003033
Disease	vitamin D measurement, COVID-19	UGT2B4 UGT2B7	1.22e-03	49	31	2	EFO_0004631, MONDO_0100096
Disease	diverticular disease	UGT2B4 UGT2B7 UGT2B11	1.92e-03	236	31	3	EFO_0009959
Disease	urinary metabolite measurement	UGT2B4 UGT2B7 UGT2B11	2.14e-03	245	31	3	EFO_0005116
Disease	serum gamma-glutamyl transferase measurement	UGT2B4 UGT2B7 JCAD TAF4 CDC42BPA	2.45e-03	914	31	5	EFO_0004532
Disease	vitamin D measurement	UGT2B4 UGT2B7 UGT2B11	5.19e-03	336	31	3	EFO_0004631
Disease	neuritic plaque measurement	UGT2B4 UGT2B7 UGT2B11	5.77e-03	349	31	3	EFO_0006798
Disease	immature platelet measurement	DOCK10 JCAD	6.95e-03	119	31	2	EFO_0803541
Disease	facial height measurement	KCNB2 NDUFV2	9.76e-03	142	31	2	EFO_0007856
Disease	testosterone measurement	UGT2B4 UGT2B7 ZCWPW1 TAF4 UGT2B11	9.96e-03	1275	31	5	EFO_0004908

Protein segments in the cluster

Peptide	Gene	Start	Entry
KRLCGTFLGGPKPPQ	CTSB	56	P07858
KGSKRGGPLPAKCIQ	BAIAP3	246	O94812
PKPGPTGVKTKPSCG	BRICD5	11	Q6PL45
CGKRLKGPPPSFEGK	GPR17	341	Q13304
KKAGGTPRKASGPPV	H1-2	26	P16403
PPPCKFGEGKLSKRL	C22orf31	91	O95567
EKSGCSAPFPRPKFG	JCAD	276	Q9P266
GKAKKLKFGLPGPPG	ERFE	101	Q4G0M1
PPKPFSCGRSGKGHK	MSL1	316	Q68DK7
CFVKIPREPGRPGKG	FOXD4	161	Q12950
GLPKGVTPAGFPKKA	PALLD	871	Q8WX93
PKDIGGSKAPVPCFG	HENMT1	301	Q5T8I9
PCQGPSKGLSPRFPK	KCNB2	776	Q92953
KPLKCIYGKPGGPLF	DOCK10	711	Q96BY6
FLKKPKAIRPGCQGG	PCARE	21	A6NGG8
PREGPPYEGKKNCKG	FAM181A	221	Q8N9Y4
CFLKVPRSPDKPGKG	FOXA2	216	Q9Y261
KKRKVDCPGPGSGAE	TAF4	1016	O00268
FSGPLSPGGSKRKPK	NHS	1041	Q6T4R5
RKPGKDPGAPDCKYG	TAF1	706	P21675
RKKGCPGSTGFPPKR	CDC42BPA	996	Q5VT25
KPKRVGAGFPKGSCP	RECQL5	651	O94762
CGKGPKRIFAPPAQK	ZCWPW1	11	Q9H0M4
FVGGLHCKPAKPLPK	UGT2B4	276	P06133
FVGGFHCKPAKPLPK	UGT2B11	276	O75310
PKKQPERCLPKGFGC	SCN11A	1011	Q9UI33
GGKVPFPRPGVCPSK	SEMA3G	371	Q9NS98
FVGGLHCKPAKPLPK	UGT2B28	276	Q9BY64
FVGGLHCKPAKPLPK	UGT2B7	276	P16662
TGPKGVKIKGCPSEP	TNS2	1206	Q63HR2
GKIPKPGPRSGRFSC	NDUFV2	211	P19404